Expression of IL32 and IL33 Genes in Tuberculosis Patients

Bushra Qasim Dhumad

doi:10.55544/jrasb.3.1.30

Authors

Bushra Qasim Dhumad Department of Medical, College of Health and Medical Techniques, Baghdad, IRAQ.

DOI:

https://doi.org/10.55544/jrasb.3.1.30

Keywords:

Tuberculosis, IL32, IL33, gene expression

Abstract

In the present case-control study, blood specimens were obtained from (60) patients infected with TB from TB center in Baghdad city, and from (60) healthy persons as a control group during the period from January 2023 to December 2023. Results of demographic picture showed that the distribution of infections in males was 31(51.7%) compared to the control group 3(51.7%) and in females was 29 (48.3%) compared to the control group 29 (48.3%). The infection distribution according to age revealed that the highest infection rate was shown to be within the age group (<20 -29), followed by (30-39) then (40-50) years, which matched with the control group (<20 -29). According to residency, there were no significant differences between rural and urban residents. Mean ±Std anti TB IgM antibodies was (2.40±1.44) in comparison with controls (0.08±0.17), with highly significant difference (P<0.01). Also, Mean ±Std anti TB IgG antibodies was (1.42±0.59) in comparison to controls (0.11±0.21), with highly a significant differences P< 0.01. Mean±Std IL-33 was (20.38±6.53) in comparison to the controls (2.28±2.48), with highly significant differences P<0.01. Also, mean ±Std IL-32 was (10.61±2.24) in comparison to the control group (1.89±2.043) with highly significant differences P< 0.01. Expression of IL32 in TB patients showed positive reaction and it was highly affected in patients with TB compared to the control group, while expression of IL33 in TB patients showed positive reaction and was highly affected in patients with TB compared to the control group.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Pai, M. Dewan, P. K. & Swaminathan, S. , Transforming tuberculosis diagnosis Nature Microbiology volume 8, pages 756–759 (2023). ORCID: orcid.org/0000-0003-3667-45361.

Subbaraman, R. Jhaveri, T. and Nathavitharana, R. R. Closing gaps in the tuberculosis care cascade: an action-oriented research agenda, J Clin Tuberc Other Mycobact Dis. 2020 May; 19: 100144. doi: 10.1016/j.jctube.2020.100144.

Falzon, D. Zignol, M. and Bastard, M. et al., The impact of the COVID-19 pandemic on the global tuberculosis epidemic, Front Immunol. 2023; 14: 1234785.doi: 10.3389/fimmu.2023.1234785.

Paleckyte, A. Dissanayake, O. and Mpagama, S. et al., Reducing the risk of tuberculosis transmission for HCWs in high incidence settings, Antimicrobial Resistance & Infection Control volume 10, Article number: 106 (2021).

Wingfield, T. Karmadwala, F. and MacPherson, P. et al., Challenges and opportunities to end tuberculosis in the COVID-19 era, Lancet Respir Med. 2021 Jun; 9(6): 556–558. doi: 10.1016/S2213-2600(21)00161-2.

Valerie A. Koeken, M. C. Verrall, A. J. et al., IL‐32 and its splice variants are associated with protection against Mycobacterium tuberculosis infection and skewing of Th1/Th17 cytokines J Leukoc Biol. 2020 Jan; 107(1): 113–118. doi: 10.1002/JLB.4AB0219-071R.

Quan, D. H. Alexander J. Kwong, J. and Philip M. Hansbro, Ph. M. et al., No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis, European Respiratory Review 2022 31: 210252; DOI: 10.1183/16000617.0252-2021.

Valerie, K. Verrall, ACM. and Ardiansyah, A. J. et al., IL-32 and its splice variants are associated with protection against Mycobacterium tuberculosis infection and skewing of Th1/Th17 cytokines. J Leukoc Biol. 2020 Jan; 107(1):113-118. doi: 10.1002/JLB.4AB0219-071R. 2019.

Murdaca, G. Paladin, F. and Tonacci, A. et al., Involvement of Il-33 in the Pathogenesis and Prognosis of Major Respiratory Viral Infections: Future Perspectives for Personalized Therapy Biomedicines. 2022 Mar; 10(3): 715. doi: 10.3390/biomedicines10030715.

Vázquez, Y. González, L. and Noguera, L. t al., the human respiratory syncytial virus (hRSV) is one of the most important causes of upper and lower respiratory tract infections in children and the main cause of bronchiolitis, Front. Immunol., doi.org/10.3389/fimmu.2019.01154.

Tran, C. Boariu, Eu. And García-Bengoa, M. et al., Serological analysis reveals differential antibody responses between TB patients and latently Front. Med., 09 October 2023 Vol. 10 - 2023 https://doi.org/10.3389/fmed.2023.1286785.

Zhao, J. Matsuba, T. and Zhang, X. et al., Comparison of antibody responses against Mycobacterium tuberculosis antigen Rv0679c in tuberculosis patients from the endemic and non-endemic regions of the Beijing genotype: a case control study, BMC Infectious Diseases volume 17, Article number: 344 (2017) Cite this article.

Sá, N. B. R. Souza, N. C. S. and Neira-Goulart, M. et al., Inflammasome genetic variants are associated with tuberculosis, HIV-1 infection, and TB/HIV-immune reconstitution inflammatory syndrome outcomes, Front Cell Infect Microbiol. 2022; 12: 962059. doi: 10.3389/fcimb.2022.962059.

Li, Wu. Deng, W. and Xie, J. The Biology and Role of Interleukin-32 in Tuberculosis, J Immunol Res. 2018; 2018: 1535194. doi: 10.1155/2018/1535194.

Khawar, M. B. Muddasir Hassan Abbasi, . H. and Sheikh, N. IL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino Sinusitis, Mediators Inflamm. 2016; 2016: 8413768. doi: 10.1155/2016/8413768.

Netea, M. G. Colorado, D. Tania Azam, T. Mycobacterium tuberculosis Induces Interleukin-32 Production through a Caspase- 1/IL-18/Interferon-γ-Dependent Mechanism, Plos Medicine 2016 https://doi.org/10.1371/journal.pmed.0030277

Al-aarag, A. H. Kamel, M. H. and Abdelgawad, E. R. et al., Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions, BMC Pulmonary Medicine vol. 19: 114 (2019).

Mohammed, L.M. Risan, F.A. Mohammed, N.S. Estimation of lnterleukin-10 and Soluble HLA-G in Aborted Women Having Herpes Simplex Virus-2 Infection Malaysian Journal of Medicine and Health Sciences, This link is disabled., 2022, 18, pp. 23–26.